Meltwind
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
IMU Biosciences
2 Jun 2026
IMU Biosciences unlocks £40m Series A led by IQ Capital and Molten Ventures to decode the immune system with high-resolution blood analysis
IMU Biosciences is a biotechnology company that uses a simple blood sample to measure over 100 million immune data points by combining high-fidelity multi-omic analysis with proprietary machine learning analytics. The platform is designed to enable disease diagnosis, monitor treatment progression, and predict treatment suitability for individual patients.
Enhanced Genomics
16 Sept 2025
Enhanced Genomics raises £14m Series A from investors to advance therapeutics pipeline with its 3D multi-omics platform
Enhanced Genomics uses a three-dimensional multi-omics platform to identify genetically validated drug targets, supporting the development of new medicines for complex common diseases.
Meltwind
- 2(12 months)
- meltwind.co.uk
- Update Information
More venture news
- 1 Jul 2026
10011001 raises £22m Series A led by Lux Capital to build AI system for critical infrastructure operators
Series AEnterprise - 2 Jul 2026
StirlingXStirlingX lands £15m Series A led by Ventura Capital and Rokos Capital Management to build sovereign data intelligence platform for critical infra
Series ADefence - 29 Jun 2026
GaussionGaussion raises £21m led by BGF and AlbionVC to enable rapid battery pack charging with external magnetic field
Series ADeep Tech
